| Michael L Berger Od Pc | |
|
6677 W Thunderbird Rd #b132, Glendale, AZ 85306-3713 | |
| (602) 978-1199 | |
| Not Available |
| Full Name | Michael L Berger Od Pc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 6677 W Thunderbird Rd #b132, Glendale, Arizona |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033388699 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | AZ0340 (Arizona) | Primary |
| Provider Name | Michael L Berger |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1992869960 PECOS PAC ID: 2860476330 Enrollment ID: I20051004000465 |
News Archive
An international study has analysed the association between childhood maltreatment and the volume of cerebral grey matter, responsible for processing information.
Vitamin A deficiency is the leading cause of preventable blindness in children. It also increases the risk of disease and death from severe infections, according to the World Health Organization.
Experts in the field of mindfulness will gather in San Diego from Feb. 7-9 to share the latest advancements in education, clinical care and research as it applies to the healthy development of youth through the application of meditation.
Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, announced today that its long-standing pharmaceutical collaborator, Novartis, has received marketing approval in Europe for Kisqali (ribociclib) plus an aromatase inhibitor as a first-line treatment in post-menopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) locally advanced or metastatic breast cancer.
Vical Incorporated announced today the achievement of key efficacy, immunogenicity and safety results in a Phase 2 trial, establishing its TransVax™ cytomegalovirus (CMV) vaccine as the first to provide evidence of protection in immunocompromised hematopoietic cell transplant (HCT) recipients, and defining a potential pathway for further development.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael L Berger Od Pc 6677 W Thunderbird Rd # B132, Glendale, AZ 85306-3713 Ph: (602) 978-1199 | Michael L Berger Od Pc 6677 W Thunderbird Rd #b132, Glendale, AZ 85306-3713 Ph: (602) 978-1199 |
News Archive
An international study has analysed the association between childhood maltreatment and the volume of cerebral grey matter, responsible for processing information.
Vitamin A deficiency is the leading cause of preventable blindness in children. It also increases the risk of disease and death from severe infections, according to the World Health Organization.
Experts in the field of mindfulness will gather in San Diego from Feb. 7-9 to share the latest advancements in education, clinical care and research as it applies to the healthy development of youth through the application of meditation.
Astex Pharmaceuticals, a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, announced today that its long-standing pharmaceutical collaborator, Novartis, has received marketing approval in Europe for Kisqali (ribociclib) plus an aromatase inhibitor as a first-line treatment in post-menopausal women with hormone receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) locally advanced or metastatic breast cancer.
Vical Incorporated announced today the achievement of key efficacy, immunogenicity and safety results in a Phase 2 trial, establishing its TransVax™ cytomegalovirus (CMV) vaccine as the first to provide evidence of protection in immunocompromised hematopoietic cell transplant (HCT) recipients, and defining a potential pathway for further development.
› Verified 8 days ago
Dr. Margarita Alicia Coca, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 7700 W Arrowhead Towne Ctr, Glendale, AZ 85308 Phone: 623-486-2020 | |
Dr. Diana Vega Hernandez, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 7260 W Bell Rd, Glendale, AZ 85308 Phone: 623-486-1888 Fax: 623-486-8001 | |
Stacie L Westen Od Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5605 W Northern Ave, Glendale, AZ 85301 Phone: 623-934-6917 | |
Jessica Chow, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5707 W Northern Ave, Suite 106, Glendale, AZ 85301 Phone: 602-512-3299 Fax: 602-512-3303 | |
Florencia Yeh, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 5865 W Utopia Rd, Glendale, AZ 85308 Phone: 623-806-7265 | |
Krissa Janae Lindsay, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 17550 N 79th Ave, Glendale, AZ 85308 Phone: 623-776-4006 |